Updated:
Harmonix
Harmonix is an early-stage venture capital firm dedicated to advancing human health and improving quality of life through meaningful innovations.
Harmonix
Harmonix is an early-stage venture capital firm dedicated to advancing human health and improving quality of life through meaningful innovations. It partners with entrepreneurs and pioneering healthcare, life sciences, and deep-tech companies. Its multidisciplinary team includes entrepreneurs, scientists, operators, and industry experts.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
North America
Country
United States
City
La Quinta
Corporate office
La Quinta, CA, United States
Principals
Maximilian Winter
General Partner
Krish Ramadurai
Partner
Sector focus
Frequently asked questions
What is Harmonix's investment strategy?
Harmonix focuses on early-stage venture and growth equity, targeting companies where software meets regulated or operationally complex sectors. The firm invests across enterprise software, digital health, AI/ML, and fintech. It favors direct investments and special-purpose vehicles over blind-pool fund commitments, enabling concentrated position sizing when it develops high conviction in a founding team.
How does Harmonix source its deals?
The firm's geographic separation from traditional venture hubs gives it access to founders who operate outside the conventional Sand Hill Road ecosystem. Harmonix cultivates relationships with entrepreneurs in California, the Northeast, and other North American innovation centers, often encountering opportunities through direct founder outreach and niche industry networks rather than competitive auction processes.
What distinguishes Harmonix's portfolio construction from a standard venture fund?
Harmonix maintains a deliberately concentrated portfolio, avoiding the spray-and-pray approach common among large venture platforms. The firm's compact team size enforces discipline: each investment receives significant post-close engagement. This operating-partner model prioritizes founder guidance on enterprise sales and compliance over rapid portfolio expansion.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: